Multiple BCG Vaccinations for Prevention of COVID-19 and Other Infectious Diseases in Type 1 Diabetes

In this randomized, double-blinded, placebo-controlled Phase II/III trial, researchers evaluated the safety and efficacy of multi-dose Bacillus Calmette-Guerin (BCG) vaccine for prevention of COVID-19 and other infectious disease in a COVID-19-unvaccinated, at-risk-community-based cohort.